Health Condition 1: G500- Trigeminal neuralgia Health Condition 2: G500- Trigeminal neuralgia Health Condition 3: G500- Trigeminal neuralgia
Conditions
Interventions
Intervention1: Palmitoyl Ascorbate (PA): 2 g/twice daily (3 Months)
Control Intervention1: Cabamazepine: 400mg/day (3 Months)
Sponsors
Parkinsons Improvement Programme
Eligibility
Inclusion criteria
Inclusion criteria: The TN cases included will be based according to the international headache classification: paroxymal unilateral pain triggered in the anatomical region of the trigeminal nerve without any sensory ormotor focal symptoms in this region.
Exclusion criteria
Exclusion criteria: Excluded from the study will be the patients with other neurological diseases, severe psychological diseases, serious chronic diseases, such as ischemic heart disease, pulmonary emphysema, and those with history of severe drug allergy. We also excluded patients treated with orally anaesthetics, allergy to vitamin C.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Reduction in TN Symptoms 2. Clinicians Experience in Managing TNTimepoint: 30mins, 90mins, 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient reported outcome measures (PROM)Timepoint: 90 mins, 48 hrs, 1 week, one month, 3 months after post intervention | — |
Countries
India
Contacts
Public ContactDr Shahnavaz Khijmatgar
A.B.Shetty Memorial Institute of Dental Sciences
Outcome results
None listed